Three products of New Horizon Health (HKG:6606) have recently been listed with the Hong Kong government's Department of Health under the Medical Device Administrative Control System (MDACS), a Tuesday bourse filing said.
The products include ColoClear, a screening test for colorectal cancer; Pupu Tube, a screening product to detect hemoglobin biomarkers associated with colorectal cancer; and UU Tube, a screening product for H. pylori.
Medical devices can be listed with the Department of Health using MDACS if they conform to the accepted standards of safety and performance.
Trading in the company's shares, which was suspended March 28, remains suspended.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.